VATS Block for Uniportal Video-assisted Thoracoscopic Surgery
NCT ID: NCT03083080
Last Updated: 2017-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2017-03-27
2019-03-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Loco-regional Analgesic Techniques in Patients Undergoing Video Assisted Thoracoscopic Surgery (VATS)
NCT07102173
Efficacy of an Erector Spinae Plane Block in VATS/RATS
NCT04400721
Sensory Anesthesia Achieved Through Different Paravertebral Block Approaches for Post-Op Pain Management After VATS Lung Resection
NCT07063602
Paravertebral Block With Brachial Plexus Block for Upper Arm Arteriovenous Fistula Surgery
NCT04720079
The Effect of the Ultrasound-guided Serratus Anterior Plane Block in Combinaison With Thoracic Paravertebral cathéter Versus Thoracic Paravertebral Cather for Perioperative Analgesia in Thoracic Surgery
NCT04024683
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VATS block (ropivacaine + epinephrine)
VATS block is the peripheral nerve block for video-assisted thoracic surgery, whose injection is administered at the site of chest wall incision.
VATS
VATS is the abbreviation of video-assisted thoracic surgery, which aims to minimize the wound for thoracic surgery and to enhance patient recovery after surgery
Ropivacaine
30 mL 0.5% ropivacaine is used to achieve VATS block
Epinephrine
1:400000 epinephrine is mixed with ropivacaine (local anesthetic) to reduce the risk of local anesthetic systemic toxicity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VATS
VATS is the abbreviation of video-assisted thoracic surgery, which aims to minimize the wound for thoracic surgery and to enhance patient recovery after surgery
Ropivacaine
30 mL 0.5% ropivacaine is used to achieve VATS block
Epinephrine
1:400000 epinephrine is mixed with ropivacaine (local anesthetic) to reduce the risk of local anesthetic systemic toxicity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Obvious coagulation abnormality
* Psychiatric patients or drug addiction
* Emergency operation or patients with a full stomach
* Difficulty in language expression
* Allergic to local anesthetic, morphine, or NSAID
* BMI \> 35
* Pregnancy
* Respiratory insufficiency
* Severe pleural adhesion
* Need for pleurodesis
* Refuse patient-controlled analgesia
* Patients with a pacemaker
* Severe liver dysfunction (serum albumin\<25g/l or Child-Pugh score≧10)
* Severe kidney dysfunction (creatinine clearance\<30ml/min)
* Inflammatory bowel disease
* Congestive heart failure (NYHA II-IV)
* Confirmed ischemic heart disease, peripheral arterial disease and/or cerebral vascular disease
* Patients with a high intra-ocular pressure (e.g. glaucoma)
* Neurological symptoms over the ipsilateral upper part of the body
20 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University WanFang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201504056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.